Executive Moves ALX appoints Dr. Barbara Klencke as interim CMO ALX Oncology Holdings (NASDAQ: ALXO) has announced the appointment of board member Barbara Klencke, MD, as interim chief medical officer, (CMO). According to ALX, Dr. Alan Sandler is departing from the role of CMO and... September 12, 2025